Pleuromutilins. Part 1: The identification of novel mutilin 14-carbamates

Bioorganic and Medicinal Chemistry

Volumn 9, Issue 5, 2001, Pages 1221-1231

  Brooks, Gerald ^a   Burgess, Wendy ^a   Colthurst, David ^a   Hinks, Jeremy D ^a   Hunt, Eric ^a   Pearson, Michael J ^a   Shea, Burdena ^a   Takle, Andrew K ^a   Wilson, Jennifer M ^a   Woodnutt, Gary ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 METHOXYBENZOYLCARBAMATE; AMOXICILLIN; ANTIBIOTIC AGENT; CARBAMIC ACID DERIVATIVE; CHLORAMPHENICOL; CLARITHROMYCIN; MUTILIN 14 CARBAMATE DERIVATIVE; PLEUROMUTILIN; PLEUROMUTILIN DERIVATIVE; SB 222734; TDM 85530; TIAMULIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; HAEMOPHILUS INFLUENZAE; LIVER MICROSOME; NONHUMAN; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; BIOLOGICAL FACTORS; CARBAMATES; DITERPENES; DRUG RESISTANCE, MICROBIAL; HAEMOPHILUS INFLUENZAE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS;

EID: 0035015698     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(00)00338-2     Document Type: Article

References (17)

1. Cohen M.L. Trends Microbiol. 2:1994;422.
2. Kavanagh F., Hervey A., Robbins W.J. Proc. Natl. Acad. Sci. U.S.A. 37:1951;570.
3. Arigoni D. Gazz. Chim. Ital. 92:1962;884.
4. Birch, A. J.; Holzapfel, C. W.; Rickards, R. W. Tetrahedron 1996, 8 (part II), 359.
5. Bonavia, G. Ph.D. Thesis, ETH Zurich, 1968, No. 4189.
6. Dobler M., Durr G.G. Cryst. Struct. Commun. 4:1975;259.
7. Hogenauer, G. In Antibiotics; Hahn, F. E. Ed.; Springer-Verlag, 1979; Vol. V, part I, pp 344-360.
8. Egger H., Reinshagen H. J. Antibiot. 29:1976;915.
9. J. Antibiot. 1976, 29, 923.
10. Proceedings of the 13th International Congress of Chemotherapy, Vienna, 28 August 1983, Abstracts PS 4.6/2-1-PS 4.6/2-14.
11. 1=Me) serves to trap the 4-epi-mutilin configuration. The reverse transformation is carried out in the presence of aqueous acid.
12. Acyl isocyanates were prepared in situ by analogy to the method described by: Arcus, C.L.; Prydal, B.S. J. Chem. Soc., 1954, 4018.
13. Berner H., Vyplel H., Schultz G. Monatsh. Chem. 114:1983;501.
14. Similar 4,14-cyclopropylmutilin derivatives have been reported by the Sandoz group Berner H., Vyplel H., Schultz G. Tetrahedron. 43:1987;765.
15. Danishefsky S. Acc. Chem. Res. 12:1979;66.
16. Miller R.D., McKean D.R. J. Org. Chem. 46:1981;2412.
17. National Committee for Clinical Laboratory Standards 1993. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, PA, 1993.